Silvercrest Asset Management Group Llc Investment Activity Analysis: Q2 2026
This analysis details observable investment activities by Silvercrest Asset Management Group Llc during the quarter ending June 30, 2026.

During the second quarter of 2026, Silvercrest Asset Management Group Llc, as reported in filings up to this date, exhibited a mixed investment pattern. The investor was simultaneously adding new positions and reducing existing ones.
On the acquisition side, Silvercrest established several notable new holdings during Q2 2026. These include investments in SOPHIA GENETICS SA, acquiring all shares previously held (or establishing a position from scratch), and significant new positions in GENTEX CORP COM and PORCH GROUP INC COM. Additionally, the investor increased their stake in VANGUARD INDEX FDS and ISHARES TR, both ETFs, by substantial percentages (100% for the former, 514.22% for the latter). Furthermore, they added shares to companies like SNAP INC COM and PULMONX CORP COM, although the latter saw a significant reduction in its position shortly after.
In terms of divestment, Silvercrest significantly reduced or exited several holdings during Q2 2026. The most pronounced exit was from PULMONX CORP COM, where the position decreased by nearly 99.4%. Similarly, they substantially cut their stake in GE HEALTHCARE TECHNOLOGIES INC COMMON STOCK (GEHC) down to just a trace amount (0.02%). Other notable reductions include CISCO SYS INC (-8.28%), DELTA AIR LINES INC DEL COM NEW (-7.62%), and several Technology sector holdings like MICROSOFT CORP COM (MSFT), SNAP INC COM, and others, as well as some ETFs.
The portfolio's structure also saw changes reflected in the sector allocations. The Technology allocation remained strong at 20.25%, while Industrials held steady at 17.52%. However, other sectors showed shifts: Financial Services slightly increased to 12.53%, Healthcare rose marginally to 10.88%, and Consumer Cyclical reached 9.53%. Energy allocation saw a slight dip to 4.82%, while Communication Services remained at 4.74%.
Overall, the portfolio's total value stood at $14.8 billion as of June 30, 2026. The investor maintained a diverse holding base with 801 positions and kept sector exposure across multiple industries. Their actions included both large buys (like IWF) and significant sells (-99.21% in LUNG), indicating active management during the quarter.